MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
Top Cited Papers
Open Access
- 1 October 2008
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (44), 29897-29903
- https://doi.org/10.1074/jbc.m804612200
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- MicroRNAs 221 and 222 Bypass Quiescence and Compromise Cell SurvivalCancer Research, 2008
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?Nature Reviews Genetics, 2008
- Oncogenes and CancerNew England Journal of Medicine, 2008
- Regulation of the p27Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferationThe EMBO Journal, 2007
- Metallothionein Expression Is Suppressed in Primary Human Hepatocellular Carcinomas and Is Mediated through Inactivation of CCAAT/Enhancer Binding Protein α by Phosphatidylinositol 3-Kinase Signaling CascadeCancer Research, 2007
- The energy sensing LKB1–AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosisNature Cell Biology, 2007
- Expression profiling identifies microRNA signature in pancreatic cancerInternational Journal of Cancer, 2006
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001